EUVIMEDEUVIMED entdecken
Multizentrische StudiePragmatische StudieRandomisierte kontrollierte StudieOpen Access

Hospital Addiction Consultation Service and Opioid Use Disorder Treatment

Krankenhaus-Konsiliardienst für Suchterkrankungen und Behandlung der Opioidkonsumstörung

Allison J Ober, Cristina Murray-Krezan, Kimberly Page, Peter D Friedmann, Jess Anderson, Karen Chan Osilla, Stephen Ryzewicz, Sergio Huerta, Mia W Mazer, Randall A Hoskinson, Richard Garvey, Alexandra Peltz und 5 weitere

JAMA Internal Medicine · 01.06.2025 · 185 (6) · 624

DOI: 10.1001/jamainternmed.2024.8586 ↗

Auf einen Blick

In dieser randomisierten Studie führte START häufiger zur Einleitung von MOUD im Krankenhaus und zur Anbindung an die OUD-Nachversorgung nach Entlassung als die Regelversorgung.

Fragestellung

Erhöht ein suchtmedizinisches Konsilteam (START) die Einleitung von MOUD im Krankenhaus und die Anbindung an die Weiterbehandlung nach Entlassung bei OUD?

Methode

1:1-randomisierte klinische Studie an 3 Krankenhäusern zwischen November 2021 und September 2023; letzter Follow-up im Dezember 2023.

Ergebnisse

325 Teilnehmende: START n=164, Regelversorgung n=161. MOUD-Start: 57,3 % vs. 26,7 %; aRR 2,10 (97,5 %-KI 1,51–2,91). Anbindung nach 30 Tagen: 72,0 % vs. 48,1 %; aRR 1,49 (97,5 %-KI 1,15–1,93).

Schlussfolgerung der Autor:innen

Laut den Autor:innen verbesserte das krankenhausbasierte, suchtmedizinische Konsilteam die evidenzbasierte Behandlung von Menschen mit OUD im Krankenhaus und die Anbindung nach der Entlassung.

Kernaussagen

  • MOUD-Start im Krankenhaus häufiger mit START
  • Anbindung an OUD-Behandlung nach Entlassung verbessert
  • Randomisierte Studie an 3 Krankenhäusern

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA Internal Medicine, erschienen am 01.06.2025. Verfasst von Allison J Ober und 16 weiteren Autor:innen. Beteiligte Einrichtung: RAND Corporation, Santa Monica, California. Hauptthemen laut MEDLINE: Opiate Substitution Treatment, Opioid-Related Disorders, Referral and Consultation. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Medications for opioid use disorder (MOUD) are effective, but hospitalized people with opioid use disorder (OUD) seldom receive MOUD while in the hospital or link with treatment after.

Objective

To test whether an addiction-focused consultation service, the Substance Use Treatment and Recovery Team (START), increases MOUD initiation during hospitalization and linkage to follow-up care after discharge. Design, Setting, and Participants This 1:1 randomized clinical trial grouped participants into the START intervention or usual care. The study was conducted between November 2021 and September 2023 at 3 hospitals in the following cities: Los Angeles, California; Albuquerque, New Mexico; and Springfield, Massachusetts. The last follow-up was in December 2023. Eligible individuals were 18 years and older and met criteria for OUD.

Intervention

START consists of an addiction medicine specialist and a care manager delivering a motivational and addiction-focused discharge planning intervention and follow-up calls. Main Outcomes and Measures Primary outcomes were the proportions of patients (1) initiating MOUD (naltrexone, buprenorphine, or methadone) during hospitalization (per electronic medical record data) and (2) successfully linking to OUD treatment within 30 days after discharge (per patient self-report).

Results

A total of 325 were consented and randomized to START (n = 164) or usual care (n = 161). Median (IQR) age was 41.0 (32.0-50.0) years. A total of 213 participants (65.5%) were male at birth, 28 (8.6%) were American Indian or Alaska Native, 21 (6.5%) were Black, 156 (48.0%) were Hispanic, and 125 (38.5%) were White. More than half, 175 (53.8%), were unhoused in the past year, and 163 (50.2%) were unemployed. START participants were more likely than usual care participants to initiate MOUD during hospitalization (94/164 [57.3%] vs 43/161 [26.7%], respectively; adjusted risk ratio [aRR], 2.10 [97.5% CI, 1.51-2.91]) and to link to OUD care after discharge (90/125 [72.0%] vs 50/104 [48.1%], respectively; aRR, 1.49 [97.5% CI, 1.15-1.93]). Conclusions and Relevance By addressing gaps in inpatient care, the hospital-based addiction-focused consultation service presented in this randomized clinical trial improved receipt of evidence-based treatment for people with OUD in the hospital and linkage to treatment after discharge.

Trial registration

ClinicalTrials.gov Identifier: NCT05086796

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opiate Substitution TreatmentOpioid-Related DisordersReferral and ConsultationAdultFemaleHumansMaleMiddle AgedBuprenorphineHospitalizationMethadoneNaltrexoneNarcotic AntagonistsPatient Discharge

Substanzen

BuprenorphineMethadoneNaltrexoneNarcotic Antagonists

Autor:innen und Institutionen

  • RAND Corporation, Santa Monica, California.
  • University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • University of New Mexico Health Sciences Center, Albuquerque.
  • University of Massachusetts Chan Medical School-Baystate, Springfield.
  • Stanford School of Medicine, Palo Alto, California.
  • Cedars-Sinai Medical Center, Los Angeles, California.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Ober, A. J., Murray-Krezan, C., Page, K., Friedmann, P. D., Anderson, J., Osilla, K. C., Ryzewicz, S., Huerta, S., Mazer, M. W., Hoskinson, R. A., Garvey, R., Peltz, A., Watkins, K. E., Nuckols, T., IsHak, W. W., Mariano, L. T., & Danovitch, I. (2025). Hospital Addiction Consultation Service and Opioid Use Disorder Treatment. JAMA Internal Medicine, 185(6), 624. https://doi.org/10.1001/jamainternmed.2024.8586

Vancouver

Ober AJ, Murray-Krezan C, Page K, Friedmann PD, Anderson J, Osilla KC, et al. Hospital Addiction Consultation Service and Opioid Use Disorder Treatment. JAMA Internal Medicine. 2025;185(6):624. doi:10.1001/jamainternmed.2024.8586

BibTeX
@article{Ober2025,
  author = {Ober, Allison J and Murray-Krezan, Cristina and Page, Kimberly and Friedmann, Peter D and Anderson, Jess and Osilla, Karen Chan and Ryzewicz, Stephen and Huerta, Sergio and Mazer, Mia W and Hoskinson, Randall A and Garvey, Richard and Peltz, Alexandra and Watkins, Katherine E and Nuckols, Teryl and IsHak, Waguih William and Mariano, Louis T and Danovitch, Itai},
  title = {Hospital Addiction Consultation Service and Opioid Use Disorder Treatment},
  journal = {JAMA Internal Medicine},
  year = {2025},
  volume = {185},
  number = {6},
  pages = {624},
  doi = {10.1001/jamainternmed.2024.8586}
}
Kostenlos starten →